Hepatitis B virus infections in apparently healthy urban Nigerians: Data from pre-vaccination tests

Journal of Infection in Developing Countries

Volumn 4, Issue 6, 2010, Pages 397-400

  Adoga, Moses P ^a,b   Gyar, Silas D ^b   Pechulano, Simon ^a   Bashayi, Obadiah D ^a   Emiasegen, Samuel E ^c   Zungwe, Timothy ^a   Iperepolu, Odunayo H ^a   Agupugo, Chinwe ^a   Agwale, Simon M ^a,d  

^a Innovative Biotech Ltd   (Nigeria)

^b NASARAWA STATE UNIVERSITY   (Nigeria)

^c General Hospital Akwanga   (Nigeria)

^d Frederick Innovative Technology Center   (United States)

Author keywords

Hepatitis B virus; Nigeria; Prevalence; Vaccination

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGERIA; PREVALENCE; SCHOOL CHILD; URBAN AREA; VEIN PUNCTURE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; ISOLATION AND PURIFICATION; MIDDLE AGED; RISK FACTOR; URBAN POPULATION; YOUNG ADULT;

HEPATITIS B VIRUS;

HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; RISK FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 77955604248     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.591     Document Type: Article

References (22)

1. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, Neitzel SM, Ward JW (2008) Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection. MMWR 57: 1-20.
2. Souza KP, Luz JA, Teles SA, Carneiro MA, Oliveira LA, Gomes AS, Dias MA, Gomes SA, Yoshida CF, Martins RM (2003) Hepatitis B and C in the Hemodialysis Unit of Tocantins, Brazil: Serological and Molecular Profiles. Menorias do Instituto Oswaldo Cruz 98: 599-603.
3. World Health Organisation (2009) Hepatitis B Fact sheet N°204. Accessed 10 June 2009. Available: http://www.who.int/csr/disease/hepatitis.
4. Forbi JC, Onyemauwa N, Gyar SD, Oyeleye AO, Entonu P, Agwale SM (2008) High prevalence of hepatitis B virus among female sex workers in Nigeria. Rev Inst Trop Sao Paulo; 50: 219-221.
5. Onyekwere CA, Anomneze EE, Wali SS (2002) Prevalence of serological markers of chronic hepatitis B virus infection in diabetes in the Lagos University Teaching Hospital, Lagos. Niger Postgrad Med J 9: 129-133.
6. Adoga MP, Banwat EB, Forbi JC, Nimzing L, Pam CR, Gyar SD, Agabi YA, Agwale SM (2009) Human Immunodeficiency Virus, Hepatitis B Virus and Hepatitis C Virus: Sero-prevalence, Co-infection and Risk Factors among Prison inmates in Nasarawa State, Nigeria. J Infect Dev Ctries 3: 539-547.
7. EASL International Consensus Conference on Hepatitis B, 13-14 September, 2002, Geneva, Switzerland (2003) Consensus Statement. Journal of Hepatology 38: 533-540.
8. Otegbayo JA, Fasola FA, Abja A (2003). Prevalence of Hepatitis B surface and e antigens, risk factors for viral acquisition and serum transaminase among blood donors in Ibadan, Nigeria. Trop Gastroenterol 24: 196-197.
9. Halim NKD, Offor E, Ajayi OI (1999) Epidemiology study of the sero-prevalence of hepatitis B surface antigen (HBsAg) and HIV-1 in blood donors. Niger J Clin Pract 2: 42-45.
10. Aganga-Williams OM, Akanmu AS, Akinsete I (1999) Prevalence of hepatitis B surface antigen among women of child-bearing age in Lagos State. African Journal of Reproductive Health 3: 45-50.
11. Bwogi J, Braka F, Makumbi I, Mishra V, Bakamutumaho B, Nanyunja M, Opio A, Downing R, Biryahwaho B, Lewis RF (2009) Hepatitis B infection is highly endemic in Uganda: findings from a National serosurvey. African Health Sciences 9: 98-108.
12. Jombo GI, Egah DZ, Banwat EB (2005). Hepatitis B virus infection in a rural settlement of northern Nigeria. Niger J Med 14: 425-428.
13. Okpalugo CE, Oguntibeju OO (2008) Prevalence of human immunodeficiency virus and hepatitis B virus in preoperative patients: Potential risk of transmission to health professionals. Pak J Biol Sci 11: 298-301.
14. Egah DZ, Banwat EB, Audu ES, Iya D, Mandong BM, Anele AA, Gomwalk NE (2007) Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria. East Mediterr Health J 13: 961-966.
15. Fasola FA, Kotila TR, Akinyemi JO (2008) Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria. Intervirology 51: 427-431.
16. Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P (2008) Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Ann Hepatol 7: 152-156.
17. Mustapha SK, Jibrin YB (2004) The prevalence of hepatitis B surface antigenaemia in patients with human immunodeficiency virus (HIV) infection in Gombe, Nigeria. Ann Afr Med 3: 10-12.
18. Lesi OA, Kehinde MO, Oguh DN, Amira CO (2007). Hepatitis B and C virus infection in Nigerian patients with HIV/AIDS. Niger Postgrad Med J 14: 129-133.
19. Odusanya OO, Meurice FP, Hoet B (2007) Nigerian medical students are at risk for hepatitis B infection. Trans R Soc Trop Med Hyg 101: 465-468.
20. Ejele OA, Ojule AC (2004) The prevalence of hepatitis B surface antigen (HBsAg) among prospective blood donors and patients in Port Harcourt, Nigeria. Niger J Med 13: 336-338.
21. Magoni M, Ekra KD, Aka LN, Sita KS, Kanga K (2009) Effectiveness of hepatitis-B vaccination in Ivory Coast: the case of the Grand Bassam health district. Ann Trop Med Parasitol 103: 519-527.
22. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y (2009) Epidemiological serosurvey of hepatitis B in China: Declining HBV Prevalence due to hepatitis B vaccination. Vaccine 27: 6550-6557.